Literature DB >> 15649575

Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males.

Kinori Kosaka1, Mitsuihiko Noda, Takeshi Kuzuya.   

Abstract

Prevention of type 2 diabetes by intensive lifestyle intervention designed to achieve and maintain ideal body weight was assessed in subjects with impaired glucose tolerance (IGT). Male subjects with IGT recruited from health-screening examinees were randomly assigned in a 4:1 ratio to a standard intervention group (control group) and intensive intervention group (intervention group). The final numbers of subjects were 356 and 102, respectively. The subjects in the control group and in the intervention group were advised to maintain body mass index (BMI) of <24.0 kg/m2 and of <22.0 kg/m2, respectively, by diet and exercise. In the intervention group, detailed instructions on lifestyle were repeated every 3-4 months during hospital visits. Diabetes was judged to have developed when two or more consecutive fasting plasma glucose (FPG) values exceeded 140 mg/dl. A 100g oral glucose tolerance test was performed every 6 months to detect improvement of glucose tolerance. The subjects were seen in an ordinary outpatient clinic. The cumulative 4-year incidence of diabetes was 9.3% in the control group, versus 3.0% in the intervention group, and the reduction in risk of diabetes was 67.4% (P < 0.001). Body weight decreased by 0.39 kg in the control group and by 2.18 kg in the intervention group (P < 0.001). The control group was subclassified according to increase and decrease in body weight. The incidence of diabetes was positively correlated with the changes in body weight, and the improvement in glucose tolerance was negatively correlated. Subjects with higher FPG at baseline developed diabetes at a higher rate than those with lower FPG. Higher 2h plasma glucose values and higher BMI values at baseline were also associated with a higher incidence of diabetes, but the differences were not significant. Subjects with a low insulinogenic index (DeltaIRI/DeltaPG 30 min after an oral glucose load) developed diabetes at a significantly higher rate than those with a normal insulinogenic index. Comparison of the BMI data and incidence of diabetes in five diabetes prevention studies by lifestyle intervention revealed a linear correlation between the incidence of diabetes and the BMI values, with the exception of the DaQing Study. However, the slope of the reduction in incidence of diabetes in the intensive intervention groups was steeper than expected simply on the basis of the reduction of BMI, suggesting that the effect of lifestyle intervention cannot be solely ascribed to the body weight reduction. We conclude that lifestyle intervention aimed at achieving ideal body weight in men with IGT is effective and can be conducted in an outpatient clinic setting.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15649575     DOI: 10.1016/j.diabres.2004.06.010

Source DB:  PubMed          Journal:  Diabetes Res Clin Pract        ISSN: 0168-8227            Impact factor:   5.602


  149 in total

Review 1.  Metformin for diabetes prevention: insights gained from the Diabetes Prevention Program/Diabetes Prevention Program Outcomes Study.

Authors:  Vanita R Aroda; William C Knowler; Jill P Crandall; Leigh Perreault; Sharon L Edelstein; Susan L Jeffries; Mark E Molitch; Xavier Pi-Sunyer; Christine Darwin; Brandy M Heckman-Stoddard; Marinella Temprosa; Steven E Kahn; David M Nathan
Journal:  Diabetologia       Date:  2017-08-02       Impact factor: 10.122

2.  Standards of medical care in diabetes--2011.

Authors: 
Journal:  Diabetes Care       Date:  2011-01       Impact factor: 19.112

3.  Stopping the cardiovascular disease continuum: Focus on prevention.

Authors:  Steven G Chrysant
Journal:  World J Cardiol       Date:  2010-03-26

4.  [Screening and prevention of diabetes].

Authors:  P E H Schwarz
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

Review 5.  Lifestyle interventions in preventing new type 2 diabetes in Asian populations.

Authors:  Pietro Amedeo Modesti; Giorgio Galanti; Piergiuseppe Cala'; Maria Calabrese
Journal:  Intern Emerg Med       Date:  2015-10-16       Impact factor: 3.397

6.  Oral Recombinant Methioninase Inhibits Diabetes Onset in Mice on a High-fat Diet.

Authors:  Yoshihiko Tashiro; Qinghong Han; Yuying Tan; Norihiko Sugisawa; Jun Yamamoto; Hiroto Nishino; Sachiko Inubushi; Y U Sun; Guangwei Zhu; Hyein Lim; Takeshi Aoki; Masahiko Murakami; Michael Bouvet; Robert M Hoffman
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

Review 7.  Benefit of lifestyle-based T2DM prevention is influenced by prediabetes phenotype.

Authors:  Matthew D Campbell; Thirunavukkarasu Sathish; Paul Z Zimmet; Kavumpurathu R Thankappan; Brian Oldenburg; David R Owens; Jonathan E Shaw; Robyn J Tapp
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

8.  Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS).

Authors:  J Lindström; M Peltonen; J G Eriksson; P Ilanne-Parikka; S Aunola; S Keinänen-Kiukaanniemi; M Uusitupa; J Tuomilehto
Journal:  Diabetologia       Date:  2012-10-24       Impact factor: 10.122

9.  Antiobesity effect of Pediococcus pentosaceus LP28 on overweight subjects: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  F Higashikawa; M Noda; T Awaya; N Danshiitsoodol; Y Matoba; T Kumagai; M Sugiyama
Journal:  Eur J Clin Nutr       Date:  2016-03-09       Impact factor: 4.016

Review 10.  The Case for Diabetes Population Health Improvement: Evidence-Based Programming for Population Outcomes in Diabetes.

Authors:  Sherita Hill Golden; Nisa Maruthur; Nestoras Mathioudakis; Elias Spanakis; Daniel Rubin; Mihail Zilbermint; Felicia Hill-Briggs
Journal:  Curr Diab Rep       Date:  2017-07       Impact factor: 4.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.